Atrial therapies reduce atrial arrhythmia burden in defibrillator patients

Paul Andrew Friedman, Barbara Dijkman, Eduardo N. Warman, H. Amy Xia, Rahul Mehra, Marshall S. Stanton, Stephen C. Hammill

Research output: Contribution to journalArticle

136 Citations (Scopus)

Abstract

Background - Approximately 25% of patients who receive an implantable cardioverter-defibrillator (ICD) to treat ventricular tachyarrhythmias have documented atrial tachyarrhythmias before implantation. This study assessed the ability of device-based prevention and termination therapies to reduce the burden of spontaneous atrial tachyarrhythmias. Methods and Results - Patients with a standard indication for the implantation of an ICD and 2 episodes of atrial tachyarrhythmias in the preceding year received a dual-chamber ICD (Medtronic 7250 Jewel AF) that uses pacing and shock therapies for prevention and/or termination of atrial tachyarrhythmias. In a multicenter trial, patients were randomized to 3-month periods with atrial therapies "on" or "off" and subsequently crossed over. Analysis was performed on the 52 of 269 patients who had episodes of atrial tachyarrhythmia and had ≥30 days of follow-up with atrial therapies on and off. The atrial therapies resulted in a reduction of atrial tachyarrhythmia burden from a mean of 58.5 to 7.8 h/mo. A paired analysis (Wilcoxon signed-rank test) showed that the median difference in burden (1.1 h/mo) was highly significant (P=0.007). When the subgroup of 41 patients treated only with atrial pacing therapies was analyzed, the reduction in burden persisted (P=0.01). Conclusions - In this study, patients with a standard ICD indication and atrial tachyarrhythmias had a significant reduction in atrial tachyarrhythmia burden with use of atrial pacing and shock therapies.

Original languageEnglish (US)
Pages (from-to)1023-1028
Number of pages6
JournalCirculation
Volume104
Issue number9
StatePublished - Aug 28 2001

Fingerprint

Defibrillators
Tachycardia
Cardiac Arrhythmias
Implantable Defibrillators
Convulsive Therapy
Therapeutics
Aptitude
Nonparametric Statistics
Multicenter Studies
Equipment and Supplies

Keywords

  • Atrial flutter
  • Atrium
  • Defibrillation
  • Fibrillation
  • Pacing
  • Tachyarrhythmias

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Friedman, P. A., Dijkman, B., Warman, E. N., Xia, H. A., Mehra, R., Stanton, M. S., & Hammill, S. C. (2001). Atrial therapies reduce atrial arrhythmia burden in defibrillator patients. Circulation, 104(9), 1023-1028.

Atrial therapies reduce atrial arrhythmia burden in defibrillator patients. / Friedman, Paul Andrew; Dijkman, Barbara; Warman, Eduardo N.; Xia, H. Amy; Mehra, Rahul; Stanton, Marshall S.; Hammill, Stephen C.

In: Circulation, Vol. 104, No. 9, 28.08.2001, p. 1023-1028.

Research output: Contribution to journalArticle

Friedman, PA, Dijkman, B, Warman, EN, Xia, HA, Mehra, R, Stanton, MS & Hammill, SC 2001, 'Atrial therapies reduce atrial arrhythmia burden in defibrillator patients', Circulation, vol. 104, no. 9, pp. 1023-1028.
Friedman PA, Dijkman B, Warman EN, Xia HA, Mehra R, Stanton MS et al. Atrial therapies reduce atrial arrhythmia burden in defibrillator patients. Circulation. 2001 Aug 28;104(9):1023-1028.
Friedman, Paul Andrew ; Dijkman, Barbara ; Warman, Eduardo N. ; Xia, H. Amy ; Mehra, Rahul ; Stanton, Marshall S. ; Hammill, Stephen C. / Atrial therapies reduce atrial arrhythmia burden in defibrillator patients. In: Circulation. 2001 ; Vol. 104, No. 9. pp. 1023-1028.
@article{fa5d3ccee07a4be280c1a915e5d9c6c4,
title = "Atrial therapies reduce atrial arrhythmia burden in defibrillator patients",
abstract = "Background - Approximately 25{\%} of patients who receive an implantable cardioverter-defibrillator (ICD) to treat ventricular tachyarrhythmias have documented atrial tachyarrhythmias before implantation. This study assessed the ability of device-based prevention and termination therapies to reduce the burden of spontaneous atrial tachyarrhythmias. Methods and Results - Patients with a standard indication for the implantation of an ICD and 2 episodes of atrial tachyarrhythmias in the preceding year received a dual-chamber ICD (Medtronic 7250 Jewel AF) that uses pacing and shock therapies for prevention and/or termination of atrial tachyarrhythmias. In a multicenter trial, patients were randomized to 3-month periods with atrial therapies {"}on{"} or {"}off{"} and subsequently crossed over. Analysis was performed on the 52 of 269 patients who had episodes of atrial tachyarrhythmia and had ≥30 days of follow-up with atrial therapies on and off. The atrial therapies resulted in a reduction of atrial tachyarrhythmia burden from a mean of 58.5 to 7.8 h/mo. A paired analysis (Wilcoxon signed-rank test) showed that the median difference in burden (1.1 h/mo) was highly significant (P=0.007). When the subgroup of 41 patients treated only with atrial pacing therapies was analyzed, the reduction in burden persisted (P=0.01). Conclusions - In this study, patients with a standard ICD indication and atrial tachyarrhythmias had a significant reduction in atrial tachyarrhythmia burden with use of atrial pacing and shock therapies.",
keywords = "Atrial flutter, Atrium, Defibrillation, Fibrillation, Pacing, Tachyarrhythmias",
author = "Friedman, {Paul Andrew} and Barbara Dijkman and Warman, {Eduardo N.} and Xia, {H. Amy} and Rahul Mehra and Stanton, {Marshall S.} and Hammill, {Stephen C.}",
year = "2001",
month = "8",
day = "28",
language = "English (US)",
volume = "104",
pages = "1023--1028",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "9",

}

TY - JOUR

T1 - Atrial therapies reduce atrial arrhythmia burden in defibrillator patients

AU - Friedman, Paul Andrew

AU - Dijkman, Barbara

AU - Warman, Eduardo N.

AU - Xia, H. Amy

AU - Mehra, Rahul

AU - Stanton, Marshall S.

AU - Hammill, Stephen C.

PY - 2001/8/28

Y1 - 2001/8/28

N2 - Background - Approximately 25% of patients who receive an implantable cardioverter-defibrillator (ICD) to treat ventricular tachyarrhythmias have documented atrial tachyarrhythmias before implantation. This study assessed the ability of device-based prevention and termination therapies to reduce the burden of spontaneous atrial tachyarrhythmias. Methods and Results - Patients with a standard indication for the implantation of an ICD and 2 episodes of atrial tachyarrhythmias in the preceding year received a dual-chamber ICD (Medtronic 7250 Jewel AF) that uses pacing and shock therapies for prevention and/or termination of atrial tachyarrhythmias. In a multicenter trial, patients were randomized to 3-month periods with atrial therapies "on" or "off" and subsequently crossed over. Analysis was performed on the 52 of 269 patients who had episodes of atrial tachyarrhythmia and had ≥30 days of follow-up with atrial therapies on and off. The atrial therapies resulted in a reduction of atrial tachyarrhythmia burden from a mean of 58.5 to 7.8 h/mo. A paired analysis (Wilcoxon signed-rank test) showed that the median difference in burden (1.1 h/mo) was highly significant (P=0.007). When the subgroup of 41 patients treated only with atrial pacing therapies was analyzed, the reduction in burden persisted (P=0.01). Conclusions - In this study, patients with a standard ICD indication and atrial tachyarrhythmias had a significant reduction in atrial tachyarrhythmia burden with use of atrial pacing and shock therapies.

AB - Background - Approximately 25% of patients who receive an implantable cardioverter-defibrillator (ICD) to treat ventricular tachyarrhythmias have documented atrial tachyarrhythmias before implantation. This study assessed the ability of device-based prevention and termination therapies to reduce the burden of spontaneous atrial tachyarrhythmias. Methods and Results - Patients with a standard indication for the implantation of an ICD and 2 episodes of atrial tachyarrhythmias in the preceding year received a dual-chamber ICD (Medtronic 7250 Jewel AF) that uses pacing and shock therapies for prevention and/or termination of atrial tachyarrhythmias. In a multicenter trial, patients were randomized to 3-month periods with atrial therapies "on" or "off" and subsequently crossed over. Analysis was performed on the 52 of 269 patients who had episodes of atrial tachyarrhythmia and had ≥30 days of follow-up with atrial therapies on and off. The atrial therapies resulted in a reduction of atrial tachyarrhythmia burden from a mean of 58.5 to 7.8 h/mo. A paired analysis (Wilcoxon signed-rank test) showed that the median difference in burden (1.1 h/mo) was highly significant (P=0.007). When the subgroup of 41 patients treated only with atrial pacing therapies was analyzed, the reduction in burden persisted (P=0.01). Conclusions - In this study, patients with a standard ICD indication and atrial tachyarrhythmias had a significant reduction in atrial tachyarrhythmia burden with use of atrial pacing and shock therapies.

KW - Atrial flutter

KW - Atrium

KW - Defibrillation

KW - Fibrillation

KW - Pacing

KW - Tachyarrhythmias

UR - http://www.scopus.com/inward/record.url?scp=0035964323&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035964323&partnerID=8YFLogxK

M3 - Article

C2 - 11524396

AN - SCOPUS:0035964323

VL - 104

SP - 1023

EP - 1028

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 9

ER -